Zhejiang Xianju Pharmaceutical Co Ltd (002332):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhejiang Xianju Pharmaceutical Co Ltd (002332) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9388
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhejiang Xianju Pharmaceutical Co Ltd (Zhejiang Xianju Pharmaceutical) is a contract manufacturer of API and formulations. The company offers products such as ingredients, active pharmaceutical ingredients, steroids and hormones, pharmaceutical products, and finished formulations, among others. Its active pharmaceutical ingredients comprise steroid drugs, male hormones and female hormones, among others. Zhejiang Xianju Pharmaceutical’s finished formulations include tablets, capsules, granules, soft capsules, powder inhalation, creams, gels, injections, and powder-injections, among others. The company offers services including contract manufacturing services, technical and scientific support services, production services, and research and development services, among others. Zhejiang Xianju Pharmaceutical is headquartered in Taizhou, China.

Zhejiang Xianju Pharmaceutical Co Ltd (002332) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
Zhejiang Xianju Pharma Receives Regulatory Approval for Private Placement of Shares for USD144.2 Million 9
Debt Offering 11
Zhejiang Xianju Pharmaceutical Plans to Raise USD58.1 Million in Public Offering of Medium-Term Notes 11
Acquisition 12
Zhejiang Xianju Pharma Acquires Effechem and Newchem for USD129.8 Million 12
Zhejiang Xianju Pharmaceutical Co Ltd – Key Competitors 13
Zhejiang Xianju Pharmaceutical Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Zhejiang Xianju Pharma Receives Regulatory Approval for Private Placement of Shares for USD144.2 Million 9
Zhejiang Xianju Pharmaceutical Plans to Raise USD58.1 Million in Public Offering of Medium-Term Notes 11
Zhejiang Xianju Pharma Acquires Effechem and Newchem for USD129.8 Million 12
Zhejiang Xianju Pharmaceutical Co Ltd, Key Competitors 13
Zhejiang Xianju Pharmaceutical Co Ltd, Other Locations 14
Zhejiang Xianju Pharmaceutical Co Ltd, Subsidiaries 14

List of Figures
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Xianju Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Zhejiang Xianju Pharmaceutical Co Ltd (002332):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clean Energy Finance Corp:電力:M&Aディール及び事業提携情報
    Summary Clean Energy Finance Corp (CEFC) is a statutory authority that provides investments for clean energy projects including renewable energy, energy efficiency and low emissions technologies. The authority financing structures include project finance, climate bonds and equity funds, aggregation …
  • CAS Medical Systems Inc (CASM):企業の財務・戦略的SWOT分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Babcock & Wilcox Enterprises Inc (BW):電力:M&Aディール及び事業提携情報
    Summary Babcock & Wilcox Enterprises, Inc. (Babcock & Wilcox) is a provider of technology-based advanced fossil and renewable power generation and environmental equipment. The company offers a range of biomass-fired boilers products such as supercritical boiler, waste-to-energy boilers, heat recover …
  • The Nisshin OilliO Group Ltd (2602):企業の財務・戦略的SWOT分析
    The Nisshin OilliO Group Ltd (2602) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Severoceske doly as:企業の戦略・SWOT・財務情報
    Severoceske doly as - Strategy, SWOT and Corporate Finance Report Summary Severoceske doly as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genentech, Inc.:企業のM&A・事業提携・投資動向
    Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genentech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Chembio Diagnostic Inc (CEMI):企業の財務・戦略的SWOT分析
    Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hallmark Cards, Inc.:企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Exponent Inc (EXPO):企業の財務・戦略的SWOT分析
    Summary Exponent Inc (Exponent), formerly Failure Analysis Associates Inc, is an engineering and scientific consulting company that provides technical solutions. The company provides engineering services in biomechanics, buildings and structures, biomedical engineering, civil engineering, electrical …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務情報
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cal-Maine Foods Inc (CALM):企業の財務・戦略的SWOT分析
    Cal-Maine Foods Inc (CALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • E.Sun Financial Holding Co Ltd:企業の戦略・SWOT・財務情報
    E.Sun Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary E.Sun Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Inmarsat Plc (ISAT):企業の財務・戦略的SWOT分析
    Inmarsat Plc (ISAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Air France-KLM SA:戦略・SWOT・企業財務分析
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Barrick Gold Corporation:戦略・SWOT・企業財務分析
    Barrick Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Greatcell Solar Ltd (GSL)-エネルギー分野:企業M&A・提携分析
    Summary Greatcell Solar Ltd (Greatcell Solar), formerly Dyesol Limited, is a renewable energy company that develops and commercializes Perovskite Solar Cells (PSC) or solid-state dye solar cell (DSC), the third generation photovoltaic technology. The company develops a range of PSC chemicals, compon …
  • Expanesthetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Expanesthetics Inc (Expanesthetics) is a developer of anesthetic and analgesic agents. The company develops inhalation anesthetic agents used in surgical procedures. It offers CNS drug development programs for various types of pains and indications such as post-operative pain, traumatic inju …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Electrabel SA:企業の戦略的SWOT分析
    Electrabel SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆